FdaApplication
NDA 211367
Identifiers
- fda_app_no: NDA211367
Properties
| Property | Value |
|---|---|
| applicant_name | EXELTIS USA INC |
| application_type | NDA |
| approval_date | 2019-05-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SLYND | DROSPIRENONE | 4MG | TABLET;ORAL |
1 product